Patologisk myopi Der er udført en dobbelt- maskeret, placebokontrolleret, randomiseret, multicenter, klinisk undersøgelse (BPD OCR 003 PM [VIP- PM]) hos patienter med subfoveal choroidal neovaskularisation forårsaget af patologisk myopi.
Pathological myopia One multicentre, double-masked, placebo-controlled, randomised study (BPD OCR 003 PM [VIP- PM]) was conducted in patients with subfoveal choroidal neovascularisation caused by pathological myopia.